4.4 Article

Teratoma of the Sellar Region: a Case Report

Journal

ENDOCRINE PATHOLOGY
Volume 28, Issue 4, Pages 315-319

Publisher

HUMANA PRESS INC
DOI: 10.1007/s12022-016-9465-0

Keywords

Pituitary; Teratoma; Pathology; Case report

Funding

  1. Novartis Pharma GmbH (Nuremberg, Germany)
  2. Novo Nordisk Pharma GmbH (Mainz, Germany)
  3. Pfizer Pharma GmbH (Berlin, Germany)
  4. Ipsen Pharma GmbH (Berlin, Germany)

Ask authors/readers for more resources

The case report describes a teratoma of the sellar region with a gland forming and an immature, relatively clear undifferentiated component without signs of anaplasia. Both components express TTF-1 indicating their presumable origin in the neurohypophysis as part of the circumventricular organs. The differential diagnosis includes pituitary adenoma and spindle cell oncocytoma with inclusion of Rathke's cleft cyst, pituitary blastoma, yolk sac tumor, and other germ cell tumors. The prognosis is the same as in the immature teratomas in the gonads, specifically unclear.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available